STRYKER CORP (SYK) FY2024 YTD Q3 P&L / Income Statement

STRYKER CORP (SYK) FY2024 YTD Q3 P&L / Income Statement

Income statement for 2024-01-01 through 2024-09-30. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

16,159,000,000 US dollars

Cost of sales

5,893,000,000 US dollars

Gross profit

10,266,000,000 US dollars

Total operating expenses

7,158,000,000 US dollars

Operating income

3,108,000,000 US dollars

Other income (expense), net

negative 144,000,000 US dollars

Earnings before income taxes

2,964,000,000 US dollars

Income taxes

517,000,000 US dollars

Net earnings

2,447,000,000 US dollars

MedSurg and Neurotechnology - Endoscopy

2,383,000,000 US dollars

MedSurg and Neurotechnology - Instruments

2,044,000,000 US dollars

MedSurg and Neurotechnology - Medical

2,710,000,000 US dollars

MedSurg and Neurotechnology - Neuro Cranial

1,237,000,000 US dollars

MedSurg and Neurotechnology - Neurovascular

966,000,000 US dollars

Orthopaedics and Spine - Hips

1,241,000,000 US dollars

Orthopaedics and Spine - Knees

1,760,000,000 US dollars

Orthopaedics and Spine - Other

396,000,000 US dollars

Orthopaedics and Spine - Spine

911,000,000 US dollars

Orthopaedics and Spine - Trauma and Extremities

2,511,000,000 US dollars

Research, development and engineering expenses

1,108,000,000 US dollars

Selling, general and administrative expenses

5,583,000,000 US dollars

Amortization of intangible assets

467,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.